Louis G Lange's Net Worth

$30 Million

Who is Louis G Lange?

Louis G Lange has an estimated net worth of $30 Million. This is based on reported shares across multiple companies, which include GILEAD SCIENCES INC, Epiphany Technology Acquisition Corp., CymaBay Therapeutics, Inc., Esperion Therapeutics, Inc., BioPlus Acquisition Corp., Audentes Therapeutics, Inc., MAXYGEN INC, and CV THERAPEUTICS INC.

SEC CIK

Louis G Lange's CIK is 0001238401

Past Insider Trading and Trends

2007 was Louis G Lange's most active year for acquiring shares with 20 total transactions. Louis G Lange's most active month to acquire stocks was the month of November. 2018 was Louis G Lange's most active year for disposing of shares, totalling 32 transactions. Louis G Lange's most active month to dispose stocks was the month of November. 2009 saw Louis G Lange paying a total of $8,705,941.78 for 1,052,448 shares, this is the most they've acquired in one year. In 2020 Louis G Lange cashed out on 368,575 shares for a total of $18,922,500.00, their largest year based on trade value.